Quetiapine Fumarate
Product Images NDC 64725-0149

4 FDA label images from Tya Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 64725-0149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (64725 0149)

Label Image (64725 0149)
Label for Quetiapine Fumarate 300 mg tablets showing a package quantity of 60 tablets. The label indicates prescription only, original manufacturer INTAS PHARMA, and repackaged by T.Y.A. Pharmaceuticals in Tallahassee, Florida. It includes placeholders for lot number and expiration date, a barcode, and a note to see the package insert for dosing information.*
FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)
A Kaplan-Meier curve showing the proportion of patients with relapse (%) over time in weeks for two treatment groups labeled QTP+LIVAL and PLA+LIVAL. The y-axis indicates relapse percentage from 0 to 100%, and the x-axis shows time from 0 to 100 weeks. The graph compares relapse rates between the two groups over the study period.*
FDA Label Image

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)
A Kaplan-Meier plot showing the proportion of patients with relapse (%) over time (weeks) for two groups: QTP + LI/VAL (Quetiapine fumarate plus lithium/valproate) represented by a dashed line, and PLA + LI/VAL (Placebo plus lithium/valproate) represented by a solid line. The graph illustrates differences in relapse rates during the study period up to approximately 90 weeks.*
FDA Label Image

Chemstructure (Quetiapine Str)

Chemstructure (Quetiapine Str)
Chemical structure diagram of quetiapine fumarate showing the molecular arrangement of its constituent atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.